Warfarin use and the risk of valvular calcification

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 12, 2009, Pages 2023-2027

  Lerner, R G ^a   Aronow, W S ^a   Sekhri, A ^a   Palaniswamy, C ^a   Ahn, C ^b   Singh, T ^a   Sandhu, R ^a   Mcclung, J A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aortic valve calcification; Mitral annular calcification; Mitral valve calcification; Warfarin

Indexed keywords

CALCIUM BINDING PROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN; WARFARIN;

AGED; AORTA VALVE; ARTICLE; BIOSYNTHESIS; CALCINOSIS; CHEMICALLY INDUCED DISORDER; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; MITRAL VALVE; PATHOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK; RISK FACTOR;

AGED; AGED, 80 AND OVER; AORTIC VALVE; ATRIAL FIBRILLATION; CALCINOSIS; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; WARFARIN;

EID: 77449151099     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03630.x     Document Type: Article

References (22)

1. Pettifor JM, Benson R. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 1975; 86: 459-62.
2. Howe AM, Lipson AH, De Silva M, Ouvrier R, Webster WS. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. Am J Med Genet 1997; 71: 391-6.
3. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 385: 78-81.
4. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-7.
5. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and Vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-27.
6. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003; 1: 178-85.
7. Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 1998; 32: 514-8.
8. Farzaneh-Far A, Proudfoot D, Shanahan C, Weissberg PL. Vascular and valvar calcification: recent advances. Heart 2001; 85: 13-7.
9. Spronk HMH, Soute BAM, Schurgers LJ, Cleutjens JPM, Thijssen HHW, De Mey JGR, Vermeer C. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 2001; 289: 485-90.
10. Schurgers LJ, Aebert H, Vermeer C, Bültmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 2004; 104: 3231-2.
11. Schori TR, Stungis GE. Long-term warfarin treatment may induce arterial calcification in humans: case report. Clin Invest Med 2004; 27: 107-9.
12. Koos R, Mahnken AH, Mühlenbruch G, Brandenburg V, Pflueger B, Wildberger JE, Kühl HP. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005; 96: 747-9.
13. Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Ross A. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007; 20: 417-22.
14. Gast GC, De Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, Van Der Schouw YT. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009; 19: 504-10.
15. Schurgers LJ, Cranenburg ECM, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 2008; 100: 593-603.
16. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, Van Der Schouw YT. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009; 203: 489-93.
17. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008; 45: 427-36.
18. Spronk HMH, Soute BAM, Schurgers LJ, Thijssen HHW, De Mey JGR, Vermeer CJ. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003; 40: 531-7.
19. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res 2008; 122: 411-7.
20. Teichert M, Visser LE, Van Schaik RH, Hofman A, Uitterlinden AG, De Smet PA, Witteman JC, Stricker BH. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2008; 28: 771-6.
21. Braam LA, Hoeks AP, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C. Beneficial effects of Vitamin D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004; 91: 373-80.
22. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, Van Der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-5.